he never said no more raises. there was always one more raise associated with the new listing. the question is can he stretch the budget that far. extra funds are due this quarter from the trials already signed which will help but it's still going to be tight. having the pulse approval will help getting investors on board but they'll want their pound of salt to go with it
Add to My Watchlist
What is My Watchlist?
